Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A; Hemophilia B”

Showing 20 of 0 results

Not applicableStudy completedNCT03901755
What this trial is testing

An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B

Who this might be right for
Hemophilia B
Swedish Orphan Biovitrum 151
Testing effectiveness (Phase 2)UnknownNCT02463591
What this trial is testing

Reversal of Dabigatran With Prothrombin Complex Concentrate

Who this might be right for
Drug Action Reversal
University Medical Center Groningen 12
Not applicableStudy completedNCT05804734
What this trial is testing

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia

Who this might be right for
Hemophilia AHemophilia BAnticoagulant-induced Bleeding
Groupe Maladies hémorragiques de Bretagne 54
Early research (Phase 1)Study completedNCT02571569
What this trial is testing

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 32
Large-scale testing (Phase 3)Active Not RecruitingNCT04083781
What this trial is testing

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors

Who this might be right for
Haemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 134
Testing effectiveness (Phase 2)Ended earlyNCT00076557
What this trial is testing

Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B

Who this might be right for
Hemophilia B
Avigen 15
Post-approval studies (Phase 4)UnknownNCT04534751
What this trial is testing

Factor In the Initial Resuscitation of Severe Trauma 2 Patients

Who this might be right for
Traumatic HemorrhageCoagulopathyMassive Hemorrhage
University Health Network, Toronto 350
Not applicableStudy completedNCT01510418
What this trial is testing

Socialization of Adult Men With Congenital Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Dana-Farber Cancer Institute 27
Not applicableStudy completedNCT00581438
What this trial is testing

Study Evaluating Approach to Treatment of Haemophilia A and B in Spain

Who this might be right for
Hemophilia AHemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 52
Large-scale testing (Phase 3)Study completedNCT00141843
What this trial is testing

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 100
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Testing effectiveness (Phase 2)Study completedNCT03370172
What this trial is testing

BAX 888 in Male Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Large-scale testing (Phase 3)Study completedNCT02053792
What this trial is testing

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 97
Large-scale testing (Phase 3)Looking for participantsNCT07545395
What this trial is testing

Safety of KN057 Prophylaxis in Patients With Haemophilia A or B

Who this might be right for
Hemophilia A or B
Suzhou Alphamab Co., Ltd. 70
Large-scale testing (Phase 3)Study completedNCT03587116
What this trial is testing

Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Who this might be right for
Hemophilia BHemophilia A
Pfizer 212
Early research (Phase 1)Study completedNCT00956345
What this trial is testing

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 18
Early research (Phase 1)Study completedNCT01562457
What this trial is testing

Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 30
Not applicableStudy completedNCT00882778
What this trial is testing

PROPACT: Retrospective Prophylaxis Patient Case Collection

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 86
Early research (Phase 1)Study completedNCT01288391
What this trial is testing

Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation